Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8940752 Pyrimidinones as PI3K inhibitors

Patent 8940752 was granted and assigned to Incyte on January, 2015 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Brian W. Metcalf0

Yun-Long Li0

Date of Patent

January 27, 2015

0

Patent Application Number

128249240

Date Filed

June 28, 2010

0

Patent Citations Received

US Patent 11819505 Heterocyclylamines as PI3K inhibitors

0

US Patent 11773102 Heterocyclic compounds as PI3K-γ inhibitors

US Patent 11926630 Tertiary alcohols as PI3K-γ inhibitors

0

US Patent 12024522 Salts and processes of preparing a PI3K inhibitor

0

US Patent 11999751 Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors

0

US Patent 11952367 Pyridine and pyridimine compounds as PI3K-gamma inhibitors

0

Patent Primary Examiner

0

Patent abstract

The present invention provides pyrimidinones that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, for example, inflammatory disorders, immune-based disorders, cancer, and other diseases.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8940752 Pyrimidinones as PI3K inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool